Clinical Presentation and Outcomes in Patients at Risk of Type II Myocardial InfarctioN in the emerGency Department.

CompletedOBSERVATIONAL
Enrollment

1,000

Participants

Timeline

Start Date

July 10, 2019

Primary Completion Date

July 9, 2020

Study Completion Date

July 9, 2020

Conditions
Myocardial Oxygenation ImbalanceMyocardial Infarction
Interventions
OTHER

Follow-up

Onset of Major Adverse Cardiovascular Event of death from all causes will be collected at 3 and 6 months after inclusion.

Trial Locations (1)

69003

Hôpital Edouard Herriot, Lyon

All Listed Sponsors
lead

Hospices Civils de Lyon

OTHER

NCT03953651 - Clinical Presentation and Outcomes in Patients at Risk of Type II Myocardial InfarctioN in the emerGency Department. | Biotech Hunter | Biotech Hunter